Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-07-20Clinical Trial Update: Study of Anti-telomerase T CD4 Immunity in Melanoma [NA]
A clinical trial update about a study examining anti-telomerase T CD4 immunity in melanoma.
-
CLINICAL_TRIALS trial_result · 2016-07-15Clinical Trial Update: Vaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells [Phase 2]
Phase 2 trial evaluating an autologous tumor cell and dendritic cell vaccine for metastatic melanoma; the study is completed.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung [Phase 2]
Phase 2 trial evaluating aerosolized sargramostim for metastatic melanoma to the lung is completed.
-
CLINICAL_TRIALS trial_result · 2016-07-12Clinical Trial Update: A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination [NA]
This clinical trial update compares educational interventions designed to teach melanoma patients how to perform skin self-examinations and …
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Everolimus in Treating Patients With Stage IV Melanoma [Phase 2]
Phase 2 trial evaluating everolimus for stage IV melanoma has been completed. The update summarizes the trial results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-06Clinical Trial Update: Inhaled Sargramostim in Treating Patients With Melanoma Metastatic to the Lung [Phase 1]
Phase 1 clinical trial evaluating inhaled sargramostim for melanoma metastatic to the lung has completed.
-
CLINICAL_TRIALS research · 2016-07-01Clinical Trial Update: Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma [NA]
A completed clinical trial update describes a diagnostic study designed to predict the risk of metastatic cancer in patients with Stage I or…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial of immunotherapy using tumor-infiltrating lymphocytes for metastatic melanoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: Chemotherapy Followed by ESO-1 Lymphocytes and Aldesleukin to Treat Metastatic Cancer [Phase 2]
Phase 2 trial investigating chemotherapy followed by ESO-1 lymphocytes and aldesleukin in metastatic cancer was terminated; results posted i…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: DNA Repair Inhibitor & Irradiation on Melanoma [Phase 1]
Phase 1 trial evaluating a DNA repair inhibitor in combination with irradiation for melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Stage IV Melanoma [Phase 2]
A Phase 2 trial of RO4929097, a gamma-secretase/Notch signaling pathway inhibitor, in stage IV melanoma was terminated. Results from the stu…
-
CLINICAL_TRIALS research · 2016-06-10Clinical Trial Update: Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment [NA]
An ongoing clinical trial is exploring markers of primary or acquired resistance to anticancer therapies in melanoma and lung cancers; curre…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Interferon Toxicities in Melanoma Treatment
The document reports observed toxicities associated with interferon therapy in the treatment of Stage III melanoma, based on a completed cli…
-
CLINICAL_TRIALS trial_result · 2016-06-09Clinical Trial Update: Trial of Ipilimumab After Isolated Limb Perfusion, in Patients With Metastases Melanoma [Phase 2]
A Phase 2 trial evaluated ipilimumab after isolated limb perfusion in patients with in-transit metastatic melanoma (Stage IIIB-IIIC); the st…
-
FDA approval · 2016-05-31FDA Approved: COTELLIC — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for COTELLIC (cobimetinib) submitted by Genentech, Inc.
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma [Phase 2]
Phase 2 trial of the Aurora A kinase inhibitor alisertib (MLN8237) in patients with unresectable stage III–IV melanoma was terminated, with …
-
CLINICAL_TRIALS trial_result · 2016-05-26Clinical Trial Update: Quality of Life and Surgical Late Effects of Melanoma Treatment
Clinical trial evaluating quality of life and surgical late effects after melanoma treatment has completed.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma [Phase 1]
Phase 1 safety study of the GVAX melanoma vaccine with or without cyclophosphamide for patients with surgically resected melanoma has comple…
-
CLINICAL_TRIALS trial_result · 2016-05-23Clinical Trial Update: Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting
A completed clinical trial assessing the prevalence of pain and associated risk factors among outpatient patients with sarcoma or melanoma.
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma [Phase 2]
Phase 2 trial of a NY-ESO-1–targeted T cell receptor therapy in NY-ESO-1 expressing metastatic melanoma was terminated, with results posted …
-
CLINICAL_TRIALS withdrawal · 2016-05-09Clinical Trial Update: Biomarker Correlates of Hypoxia in Metastatic Melanoma [Phase 2]
The Phase 2 trial investigating biomarker correlates of hypoxia in metastatic melanoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma [Phase 3]
Phase 3 trial results for high-dose interferon alfa-2b in stage II or stage III melanoma have been posted.
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients [Phase 2]
Phase 2 trial investigating platinum-based chemotherapy to improve dendritic cell vaccine efficacy in melanoma; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma [Phase 1]
This phase 1 trial evaluated the combination of lenalidomide and dacarbazine in patients with metastatic melanoma and is now completed.
-
CLINICAL_TRIALS research · 2016-04-28Clinical Trial Update: Ipilimumab-induced Lung Toxicity: Observational Study
Observational study assessing the risk and characteristics of ipilimumab-associated lung toxicity in patients with metastatic melanoma.